Tapering antidepressants without routinely using taper strips
Medically reviewed by: Ruben de Groot, doctor Last reviewed:
Taper strips can be useful when very small dose reductions are required. They are not necessary for every patient. Sometimes the same clinical goal can be achieved more simply using standard medication strengths, liquid formulations or a different pharmacokinetic tapering strategy.
Why smaller reductions may be necessary
The effect of reducing an antidepressant is not identical across the entire dose range.
A reduction from a high dose to a slightly lower dose may produce a relatively small pharmacological change, whereas the final few milligrams can represent a proportionally larger step.
Modern guidance therefore recommends considering smaller proportional reductions at lower doses and adjusting the pace according to the individual's response.
Read more about hyperbolic tapering.
Four possible approaches
There is no single tapering method that is best for everyone.
Standard tablet strengths
For many people this is sufficient.
The dose can be reduced stepwise using available tablets, scored tablets or other routinely available strengths.
If clinically relevant withdrawal does not occur, a more complicated regimen is not automatically better.
Slower or more hyperbolic tapering
If symptoms emerge, smaller reductions may be needed.
This can sometimes still be achieved using ordinary medication. For other drugs, a liquid formulation can provide intermediate doses.
The tapering rate is adjusted according to tolerability.
A long-acting fluoxetine bridge
For certain serotonergic antidepressants, substitution with fluoxetine may be considered.
Fluoxetine and its active metabolite norfluoxetine have long elimination half-lives. This produces a prolonged natural decline in exposure after dose reduction or discontinuation.
A technical protocol published in 2025 describes how this property may be used in patients for whom tapering their original antidepressant has proved difficult.
This strategy is not appropriate for every medication or patient and requires, among other things, an interaction review.
Read more about fluoxetine bridging.
Taper strips or compounded formulations
In some situations, highly precise daily dosing is the most practical or best tolerated solution.
Taper strips, liquid preparations or compounded medication can then be appropriate.
We therefore do not view these methods as something that should be avoided, but neither do we assume that they are always required.
Why not automatically choose the most complicated solution?
Antidepressant tapering can take months.
A plan therefore needs to be not only pharmacologically sound but also practical to follow.
A theoretically perfect regimen has limited value if it is difficult to perform every day, creates unnecessary opportunities for dosing errors or causes avoidable costs.
We therefore first consider whether a simpler method can achieve the same clinical objective.
When can taper strips be useful?
Taper strips or other preparations allowing very small dose changes may be useful when:
- previous small reductions still caused significant withdrawal;
- no suitable liquid formulation is available;
- very small daily doses are required;
- switching to another medicine is clinically undesirable;
- a patient tolerates small daily reductions better than intermittent or larger steps.
The appropriate method depends on both the medicine and the individual's response.
Tapering is not a race
The objective is not to reach zero as quickly as possible.
The objective is a taper that:
- is medically appropriate;
- remains practical;
- allows enough time to assess each reduction;
- can be slowed if withdrawal occurs;
- allows withdrawal to be distinguished from recurrence of the original condition.
As simple as possible, as gradual as necessary
This is the principle used by the Medicatie Afbouwpoli.
We do not automatically begin with the most complex method.
We first assess:
- the medication;
- the current dose;
- its half-life;
- previous tapering attempts;
- routinely available strengths;
- available liquid formulations;
- relevant interactions;
- whether a long-acting bridging strategy is appropriate;
- whether very small individual dose reductions are actually required.
A practical tapering plan can then be selected.
Cost and accessibility
Availability and cost can legitimately form part of the decision.
A method that is theoretically available but financially or practically difficult to sustain may be less suitable in real-world care.
This does not mean that cost takes priority over medical safety. It means that we aim for the least complicated medically appropriate solution.
Sources
- NICE. Depression in adults: treatment and management (NG222) — recommendations on staged and proportional dose reduction.
- Dutch multidisciplinary guidance on tapering SSRIs and SNRIs — NHG, KNMP, NVvP and MIND.
- Shapiro B, Cohrs D. Fluoxetine substitution for deprescribing antidepressants: a technical approach. Journal of Psychiatry & Neuroscience. 2025;50(4)–E209.
Further reading
This page provides general medical information and is not an individual tapering prescription.